Morepen Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

109.58

102.23

102.23

95.56

89.96

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1,071.92

786.80

677.89

502.61

311.26

Loan funds

Secured loans

78.96

28.19

25.16

18.57

59.90

Unsecured loans

-

-

-

-

-

Total

1,260.46

917.22

805.28

616.74

461.13

Uses of funds

Fixed assets

Gross block

645.87

474.71

496.81

470.18

512.78

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

280.00

258.18

325.99

314.07

368.75

Net block

365.87

216.54

170.82

156.11

144.02

Capital work-in-progress

28.34

24.45

17.01

14.15

1.96

Investments

204.97

126.18

117.84

117.79

118.78

Net current assets

Current assets, loans & advances

1,122.02

912.14

799.86

745.21

582.74

Less : current liabilities & provisions

460.74

362.09

300.26

416.53

386.37

Total net current assets

661.28

550.05

499.60

328.69

196.37

Miscellaneous expenses not written

-

-

-

-

-

Total

1,260.46

917.22

805.28

616.74

461.13

Notes:

Book value of unquoted investments

127.20

126.18

117.84

117.79

117.69

Market value of quoted investments

79.87

-

-

-

1.31

Contingent liabilities

35.68

20.04

11.84

18.98

3.36

Number of equity sharesoutstanding (Lacs)

5479.54

5111.69

5111.69

4778.26

4498.26